Clinical Trials Sponsored by KCRI

Total 292 results

Balton Sp.zo.o.
KCRI

Completed

Clinical Study to Assess the Safety and Efficacy of Mechanochemical Ablation With Flebogrif in Patients With Great Saphenous Vein Insufficiency (POLFLEB)

Chronic Venous Insufficiency, CVI

Poland
Balton Sp.zo.o.
KCRI

Completed

Prospective, Single-arm, Multicenter Study for Evaluation the Safety and Effectiveness of the ALEX Stent in a Real-world Setting of Percutaneous Coronary Interventions in Patients With Coronary Heart Disease (ALEX OCT)

Myocardial Infarction | Stable Angina | Unstable Angina

Poland
KCRI
Spectranetics Corporation

Terminated

ThromboAblation in Acute Myocardial Infarction (TAAMI)

ST Elevation Acute Myocardial Infarction

Poland
PlasFree Ltd.
KCRI

Completed

Clinical Investigation of Safety and Performance of a Medical Device (ClearPlasma) for the Treatment of Patients With Acute Upper Gastrointestinal Hemorrhage.

Acute Upper Gastrointestinal Bleeding | Acute Upper Gastrointestinal Hemorrhage

Czechia, Israel, Italy
Balton Sp.zo.o.
KCRI

Completed

Safety and Efficacy of Peripheral, Cobalt-chromium Sirolimus Eluting Stent (PERS) Versus Cobalt-chromium Stent (Neptune C) (PERS)

Peripheral Arterial Disease

Poland
Balton Sp.zo.o.
KCRI

Completed

Clinical Study to Evaluate the Safety and Effectiveness of MER® Stents in Carotid Revascularisation. (MER)

Carotid Artery Stenosis

Poland
Balton Sp.zo.o.
KCRI

Completed

Evaluation of the Usefulness of Imaging Methods and 3D Reconstruction in Percutaneous Closure Procedures of PVL. (VALE)

PVL - Paravalvular Leak

Poland
Eximo Medical Ltd.
KCRI

Completed

Safety and Effectiveness Study of Eximo's B-Laser™ Atherectomy Device for PAD Treatment

Peripheral Arterial Disease

Poland
KCRI
SIS Medical AG

Completed

Optimal Lesion Preparation With Non-compliant Balloons Before Implantation Of Bioresorbable Scaffolds (OPreNBiS)

Coronary Artery Disease | Angina, Stable | Angina, Unstable

Switzerland
Eclipse Medical Ltd.
KCRI

Recruiting

Evaluation od Safety and Performance of the Omega™ LAA (Left Atrial Appendage) Occluder and Omega™ Delivery System in Patients With Non-Valvular Atrial Fibrillation and High Bleeding Risk (Omega)

Non-Valvular Atrial Fibrillation

Denmark, Germany, Italy, Spain, United Kingdom
KCRI
Vascular Concepts Limited

Completed

A Clinical Evaluation of the ProNOVA XR Polymer Free Drug Eluting Coronary Stent System (EURONOVA)

Myocardial Ischemia

Poland
Thubrikar Aortic Valve, Inc.
KCRI

Recruiting

Safety and Performance Study of the Optimum Transcatheter Aortic Valve

Severe Aortic Stenosis

Poland
Xtrac O.S.
KCRI; Scopus Research

Active, not recruiting

Safety and Preliminary Performance of Xtrac O.S. System for Lead Extraction. (XTR)

Bradycardia

Israel
Fundacja Ośrodek Badań Medycznych
KCRI

Withdrawn

Effect of the Repeated Loading Dose of Clopidogrel and High Dose of Clopidogrel Continuous Therapy on the Platelet Aggregation Inhibition in Patients With Myocardial Infarction Undergoing Interventional Treatment. (REL-0609)

Acute Myocardial Infarction

Poland
Medical University of Warsaw
KCRI

Unknown

Restenosis Treatment With Rapamycin Eluting Stent or Paclitaxel Eluting Balloon Catheter (RESTENOZA) (ISRII)

In-Stent Restenosis

Poland
Stec, Sebastian, MD, PhD, FESC
KCRI

Recruiting

Permanent Pacemaker Implantation or Cardioneuroablation in Sinus Node Dysfunction (SANOK)

Sinus Node Dysfunction

Poland
SCRI Development Innovations, LLC

Terminated

A Study of CPX-351 (Vyxeos™) With Quizartinib for the Treatment of FLT3-ITD Mutation-Positive Acute Myeloid Leukemia

Leukemia, Myeloid, Acute

United States
SCRI Development Innovations, LLC

Completed

Utilization of the OncoCEE™ Platform to Evaluate Selected Biomarker Alterations in CTCs Isolated From Patients With MBC

Metastatic Breast Cancer

United States
SCRI Development Innovations, LLC

Withdrawn

iCORE: Collaborative Orthopedics Outcomes Registry (iCORE)

Arthroplasty, Replacement, Knee | Arthroplasty, Replacement, Hip

United States
SCRI Development Innovations, LLC

Withdrawn

Sarah Cannon Outcomes Registry

Oncology

United States
SCRI Development Innovations, LLC

Terminated

SCRI Tissue Testing Registry

Melanoma | Lymphoma | Multiple Myeloma | Myelodysplastic Syndrome

United States
Maria Sklodowska-Curie National Research Institute...
KCRI

Not yet recruiting

Nivolumab in Nasopharyngeal Cancer With Progression During or After Platinum-based Treatment (NIVONASO-21)

Nasopharyngeal Cancer

Poland
Maria Sklodowska-Curie National Research Institute...
KCRI

Not yet recruiting

Obinutuzumab Versus Rituximab for Acute Lymphoblastic Leukemia/PALG ALL7 OVERALL (PALG ALL7)

CD20-positive Acute Lymphoblastic Leukemia

Poland
Maria Sklodowska-Curie National Research Institute...
KCRI

Not yet recruiting

Total Body Irradiation and Cladribine Before Allogeneic Hematopoietic Cell Transplantation in Patients With AML (Acute Myeloid Leukemia) and Myelodysplastic Syndromes (CLARA)

Acute Myeloid Leukemia Myelodysplastic Syndromes

Poland
SCRI Development Innovations, LLC
Amgen

Completed

Carfilzomib for the Treatment of Patients With Advanced Neuroendocrine Cancers

Neuroendocrine Cancer

United States
SCRI Development Innovations, LLC
Celgene

Completed

Trial of Amrubicin as Treatment for Patients With HER2-Negative Metastatic Breast Cancer

Metastatic Breast Cancer

United States
SCRI Development Innovations, LLC
Bayer

Completed

Sorafenib/Erlotinib Versus Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer

United States
SCRI Development Innovations, LLC
Novartis

Completed

LBH589 Treatment for Refractory Clear Cell Renal Carcinoma

Renal Cell Carcinoma

United States
SCRI Development Innovations, LLC
Sanofi

Completed

Trastuzumab and Oxaliplatin in Patients With Metastatic Breast Cancer

Breast Cancer

United States
Neurocytonix, Inc.
KCRN Research, LLC

Completed

Neurocytotron on Cerebral Palsy

Cerebral Palsy

Mexico
SCRI Development Innovations, LLC
Pfizer

Completed

A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)

Colorectal Cancer

United States
SCRI Development Innovations, LLC
Novartis

Completed

Trial of Erlotinib and BKM120 in Patients With Advanced Non Small Cell Lung Cancer Previously Sensitive to Erlotinib

Non Small Cell Lung Cancer

United States
SCRI Development Innovations, LLC
Novartis

Withdrawn

Cabazitaxel and BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel

Advanced Prostate Cancer

United States
SCRI Development Innovations, LLC
Amgen

Completed

FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only

Colorectal Cancer

United States
SCRI Development Innovations, LLC
Novartis

Completed

Study of PI3 Kinase/mTOR Inhibitor BEZ235 Twice Daily for Advanced Solid Tumors

Malignant Solid Tumour

United States
SCRI Development Innovations, LLC
Bayer

Completed

Paclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian Cancer

Ovarian Cancer

United States
SCRI Development Innovations, LLC
Bayer

Completed

PK Trial of Sorafenib & Erlotinib in Patients With Refractory Solid Tumors

Refractory Solid Tumors

United States
SCRI Development Innovations, LLC
Novartis

Completed

Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma

Metastatic Melanoma

United States
SCRI Development Innovations, LLC
Bayer

Completed

Community Oncology Setting Disease Outcomes of Sorafenib (Nexavar) Use in Advanced Renal Cell Carcinoma

Renal Cell Carcinoma

United States
SCRI Development Innovations, LLC
Novartis

Terminated

LBH589 and Gemcitabine in the Treatment of Solid Tumors

Solid Tumors

United States
SCRI Development Innovations, LLC
Novartis

Completed

Imatinib and PTK787/ZK222584 in Refractory and/or Advanced Solid Tumors

Solid Tumors | Refractory Malignancy

United States
SCRI Development Innovations, LLC
GlaxoSmithKline

Completed

Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer

Small Cell Lung Cancer | Carcinoma, Small Cell

United States
SCRI Development Innovations, LLC
GlaxoSmithKline

Completed

Weekly Topotecan in Combination With Carboplatin in Two Different Schedules for Refractory and/or Advanced Solid Tumors

Cancer

United States
SCRI Development Innovations, LLC
AstraZeneca

Completed

Iressa in Poor Performance Status Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer

Lung Cancer
SCRI Development Innovations, LLC
Biogen

Completed

Rituximab and Chemotherapy Followed by Ibritumomab Tiuxetan as Treatment for Low Grade Follicular Non-Hodgkin's Lymphoma

Non-Hodgkins Lymphoma
SCRI Development Innovations, LLC
Novartis

Completed

LBH589, Paclitaxel, Carboplatin +/- Bevacizumab for Solid Tumors

Solid Tumors

United States
SCRI Development Innovations, LLC
Bayer

Completed

Rituximab and Fludarabine Followed by CAMPATH-1H in Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Non-Hodgkins Lymphoma
SCRI Development Innovations, LLC
Pfizer

Completed

Treatment Patterns in Gastrointestinal Stromal Tumors in the Community Oncology Setting

Gastrointestinal Stromal Tumors

United States
SCRI Development Innovations, LLC
Pfizer

Withdrawn

Lorlatinib in Combination With Chemotherapy in Participants With Metastatic Anaplastic Lymphoma Kinase Positive (ALK+) Non-small Cell Lung Cancer (NSCLC) Who Progressed on Single-agent Lorlatinib (NSCLC)

Lung Cancer | Non-small Cell Lung Cancer

United States
SCRI Development Innovations, LLC
Ipsen

Terminated

Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres

Gastrointestinal Neoplasms | Neuroendocrine Tumors | Carcinoid Tumors

United States

3

Subscribe